[go: up one dir, main page]

CN103304490B - Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark - Google Patents

Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark Download PDF

Info

Publication number
CN103304490B
CN103304490B CN201310240459.4A CN201310240459A CN103304490B CN 103304490 B CN103304490 B CN 103304490B CN 201310240459 A CN201310240459 A CN 201310240459A CN 103304490 B CN103304490 B CN 103304490B
Authority
CN
China
Prior art keywords
water
methanol
separation
sample
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310240459.4A
Other languages
Chinese (zh)
Other versions
CN103304490A (en
Inventor
李爱峰
孙爱玲
柳仁民
张永清
黄臻辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai No1 Biochemical & Pharmaceutical Co Ltd
Liaocheng University
Shandong University of Traditional Chinese Medicine
Original Assignee
Shanghai No1 Biochemical & Pharmaceutical Co Ltd
Liaocheng University
Shandong University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai No1 Biochemical & Pharmaceutical Co Ltd, Liaocheng University, Shandong University of Traditional Chinese Medicine filed Critical Shanghai No1 Biochemical & Pharmaceutical Co Ltd
Priority to CN201310240459.4A priority Critical patent/CN103304490B/en
Publication of CN103304490A publication Critical patent/CN103304490A/en
Application granted granted Critical
Publication of CN103304490B publication Critical patent/CN103304490B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明涉及从瓜蒌皮中分离纯化5种嘌呤及嘧啶碱(胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤及黄嘌呤)的方法,是以瓜蒌皮为原料,经过下述步骤:(1)瓜蒌皮粗提物的制备;(2)大孔吸附树脂柱粗分离;(3)半制备型高效液相色谱分离纯化:将样品1和样品2分别用半制备型高效液相色谱进行分离纯化,流动相为甲醇-水,得到高纯度的胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤及黄嘌呤5种单体化合物。工艺过程绿色环保,对环境无严重危害,综合成本低。

The present invention relates to a method for separating and purifying 5 kinds of purines and pyrimidine bases (cytosine, uracil, hypoxanthine, guanine and xanthine) from the skin of Trichosanthes quinces, using the skins of Trichosanthes as raw materials, through the following steps: ( 1) Preparation of crude extract of Trichosanthes barbatus; (2) Coarse separation with macroporous adsorption resin column; (3) Separation and purification by semi-preparative high-performance liquid chromatography: Sample 1 and sample 2 were separated by semi-preparative high-performance liquid chromatography Separation and purification are carried out, the mobile phase is methanol-water, and five monomer compounds of cytosine, uracil, hypoxanthine, guanine and xanthine are obtained with high purity. The technological process is green and environmentally friendly, has no serious harm to the environment, and has low overall cost.

Description

一种从瓜蒌皮中分离纯化5种嘌呤及嘧啶碱基的方法A method for separating and purifying 5 kinds of purine and pyrimidine bases from Trichosanthes rind

技术领域 technical field

本发明属于化工领域,具体是涉及一种从中药瓜蒌皮中分离纯化5种嘌呤及嘧啶碱基(胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤及黄嘌呤)的方法。 The invention belongs to the field of chemical industry, and in particular relates to a method for separating and purifying five kinds of purine and pyrimidine bases (cytosine, uracil, hypoxanthine, guanine and xanthine) from the skin of the traditional Chinese medicine Trichosanthes quince.

背景技术 Background technique

瓜蒌皮为葫芦科栝楼属植物栝楼(Trichosanthes kirilowii Marim.)或双边栝楼(Trichosanthes rosthornii Harms.)的干燥成熟果皮,属于常用中药,具有润肺化痰、利气宽胸等功效,临床上广泛用于治疗痰热咳嗽、痰浊黄稠、咽痛、胸痛、吐血、衄血、便秘、痈疮肿毒等症。现代药理实验及临床实践表明瓜蒌皮具有扩张冠状动脉、增加冠脉血流量、提高心肌耐缺氧能力、降低血清胆固醇、抗菌、抗癌等多种药理作用,尤其是对心血管疾病具有很好的治疗作用。 Trichosanthes kirilowii Marim. or Trichosanthes rosthornii Harms. is the dried and mature peel of Trichosanthes kirilowii Marim. or Trichosanthes rosthornii Harms. Clinically, it is widely used in the treatment of phlegm-heat cough, phlegm turbid yellow thick, sore throat, chest pain, hematemesis, epistaxis, constipation, carbuncle sores and swollen toxins. Modern pharmacological experiments and clinical practice have shown that Trichosanthes peel has various pharmacological effects such as expanding coronary arteries, increasing coronary blood flow, improving myocardial hypoxia resistance, lowering serum cholesterol, antibacterial, and anticancer, especially for cardiovascular diseases. Good therapeutic effect.

核酸包含了生物遗传信息,嘌呤、嘧啶类生物碱基是构成核酸的重要组成部分,广泛参与遗传和代谢等多种生命活动,它们的代谢异常常引起诸多严重的疾病,如肾衰竭、痛风及男性不育等。次黄嘌呤是一种非常重要的生物嘌呤碱,具有降低血压、平喘、治疗痛风等药理活性,在人体内分布广泛,能够参与调节人体内的一些重要的生理机能,还可用于治疗各种原因所致的白细胞减少症、血小板减少症等疾病,国外还报道黄嘌呤、次黄嘌呤与肿瘤细胞的生长代谢关系密切。 Nucleic acid contains biological genetic information. Purine and pyrimidine alkaloids are important components of nucleic acid, and they are widely involved in various life activities such as heredity and metabolism. Their metabolic abnormalities often cause many serious diseases, such as kidney failure, gout and Male infertility etc. Hypoxanthine is a very important biological purine base, which has pharmacological activities such as lowering blood pressure, relieving asthma, and treating gout. It is widely distributed in the human body and can participate in the regulation of some important physiological functions in the human body. It can also be used to treat various Leukopenia, thrombocytopenia and other diseases caused by various causes, foreign countries have also reported that xanthine and hypoxanthine are closely related to the growth and metabolism of tumor cells.

现已有文献报道从瓜蒌皮中提取纯化嘌呤及嘧啶类生物碱基的方法。滕勇荣[瓜蒌皮和瓜蒌皮注射液化学成分研究,山东中医药大学硕士学位论文,2011年]利用反复硅胶柱层析、大孔吸附树脂柱色谱及制备型高效液相色谱等分离手段对瓜蒌皮的化学成分进行了研究,共得到7个化合物,其中包括3个核苷类成分(腺嘌呤、鸟嘌呤核苷及6-异次黄嘌呤核苷)。时岩鹏[栝楼化学成分的研究及其α-菠菜甾醇的含量测定(I),中草药,2002年1期]利用反复硅胶柱层析对栝楼的化学成分进行了研究,自石油醚部位、氯仿部位、正丁醇部位分离得到12个化合物,其中10个得到了鉴定,包括1种核苷类成分—尿嘧啶。刘岱琳[瓜蒌的抗血小板聚集活性成分研究. 中草药,2004年12期]利用抗血小板聚集的活性追踪方法,采用Sephadex LH-20柱色谱及反复硅胶柱色谱分离,自瓜蒌中分离得到7个化合物,其中包括1种核苷类成分—腺嘌呤核苷。 A method for extracting and purifying purine and pyrimidine alkaloids from Trichosanthes rind has been reported in the literature. Teng Yongrong [Study on the chemical composition of Gualoupi and Gualoupi injection, master's degree thesis of Shandong University of Traditional Chinese Medicine, 2011] using repeated silica gel column chromatography, macroporous adsorption resin column chromatography and preparative high performance liquid chromatography to separate the The chemical constituents of the skin of Trichosanthes L. were studied, and a total of 7 compounds were obtained, including 3 nucleoside components (adenine, guanosine and 6-isosinosine). Shi Yanpeng [Research on the chemical composition of Trichosanthes and the determination of α-spinasterol (I), Chinese herbal medicine, 2002, No. 1] using repeated silica gel column chromatography to study the chemical composition of Trichosanthes, from the petroleum ether part , chloroform, and n-butanol were separated to obtain 12 compounds, 10 of which were identified, including 1 nucleoside component—uracil. Liu Dailin [Study on the anti-platelet aggregation active ingredients of Trichosanthes trichosanthes. Chinese herbal medicine, 2004, No. 12] Using the anti-platelet aggregation activity tracking method, using Sephadex LH-20 column chromatography and repeated silica gel column chromatography, 7 compounds were isolated from Trichosanthes trichosanthes. Compounds, including a nucleoside component - adenosine.

上述方法主要存在的问题是:分离过程步骤较为繁琐,有时需要使用氯仿为萃取剂或 The main problem of the above-mentioned method is: the separation process step is comparatively loaded down with trivial details, needs to use chloroform sometimes as extraction agent or

洗脱剂,对人体和环境均有严重危害,而且得到的嘌呤及嘧啶碱基的种类少,生产周期较长,生产成本较高。 The eluent has serious harm to the human body and the environment, and the types of purine and pyrimidine bases obtained are few, the production cycle is long, and the production cost is high.

发明内容 Contents of the invention

本发明的目的在于克服现有技术的不足,提供一种操作简便、绿色环保、综合成本低、生产周期短的快速从中药瓜蒌皮中分离纯化嘌呤及嘧啶碱基的方法。 The purpose of the present invention is to overcome the deficiencies of the prior art, and provide a method for quickly separating and purifying purine and pyrimidine bases from the traditional Chinese medicine Trichosanthes quince, which is easy to operate, environmentally friendly, low in overall cost, and short in production cycle.

本发明的方案如下: The scheme of the present invention is as follows:

从中药瓜蒌皮中分离纯化嘌呤及嘧啶碱基的方法,其步骤为: The method for separating and purifying purine and pyrimidine bases from the peel of the traditional Chinese medicine Trichosanthes quince, the steps are:

(1)瓜蒌皮粗提物的制备:取粉碎好的瓜蒌皮药材,用水加热回流提取,提取液经减压浓缩至相对密度为1.2左右,向浓缩液中加入95%乙醇至乙醇的浓度为70%左右,静置72 h,过滤,取上层清液,减压浓缩得粗提物; (1) Preparation of the crude extract of Trichosanthes rind: Take the crushed medicinal material of Trichosanthes piscifolia, heat and reflux with water to extract, the extract is concentrated under reduced pressure to a relative density of about 1.2, and 95% ethanol to the concentration of ethanol is added to the concentrated solution. The concentration is about 70%, let it stand for 72 hours, filter, take the supernatant, and concentrate under reduced pressure to obtain the crude extract;

(2)大孔吸附树脂柱粗分离:将瓜蒌皮粗提物溶于水中,上HPD826型大孔吸附树脂柱进行层析,先用水进行洗脱,再用浓度为5%左右的乙醇-水溶液进行洗脱,分别收集水及5%左右的乙醇-水洗脱液,前者减压浓缩,得样品1,后者减压浓缩,得样品2; (2) Coarse separation with macroporous adsorption resin column: Dissolve the crude extract of Trichosanthes piperi in water, apply HPD826 macroporous adsorption resin column for chromatography, first elute with water, and then use ethanol with a concentration of about 5%- The aqueous solution was used for elution, and water and about 5% ethanol-water eluent were collected respectively. The former was concentrated under reduced pressure to obtain sample 1, and the latter was concentrated under reduced pressure to obtain sample 2;

(3)样品1的进一步分离纯化:将样品1用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱,流动相为甲醇-水,检测波长为254 nm; (3) Further separation and purification of sample 1: The sample 1 was separated and purified by semi-preparative high performance liquid chromatography, the chromatographic column was YMC ODS-AQ column, the mobile phase was methanol-water, and the detection wavelength was 254 nm;

(4)样品2的进一步分离纯化:将样品2用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱,流动相为甲醇-水,检测波长为254 nm; (4) Further separation and purification of sample 2: The sample 2 was separated and purified by semi-preparative high performance liquid chromatography, the chromatographic column was YMC ODS-AQ column, the mobile phase was methanol-water, and the detection wavelength was 254 nm;

收集目标组分馏分,将得到的馏分减压浓缩,即得到所要分离的单体化合物。 The fractions of the target components are collected, and the obtained fractions are concentrated under reduced pressure to obtain the monomer compound to be separated.

前面所述的方法,优选的方案是,步骤(1)加热回流提取时提取时间为1-3小时,提取次数为2-6次。更加优选的是,提取时间为1.5-2.5小时(优选2小时),提取次数为3-5次(优选4次)。 In the above-mentioned method, the preferred solution is that the extraction time in step (1) heating under reflux extraction is 1-3 hours, and the number of extractions is 2-6 times. More preferably, the extraction time is 1.5-2.5 hours (preferably 2 hours), and the extraction frequency is 3-5 times (preferably 4 times).

前面所述的方法,优选的方案是,步骤(3)流动相为 0-5%的甲醇-水洗脱液(优选2%),洗脱液流速为2.5-4.5 mL/min(优选3.5 mL/min)。 The method described above, the preferred scheme is that the mobile phase of step (3) is 0-5% methanol-water eluent (preferably 2%), and the eluent flow rate is 2.5-4.5 mL/min (preferably 3.5 mL /min).

前面所述的方法,优选的方案是,步骤(4)用甲醇-水洗脱液进行洗脱时,所用甲醇的质量浓度为2%-6%(优选4%)。洗脱液流速为2.5-4.5 mL/min(优选3.5 mL/min)。 In the aforementioned method, a preferred scheme is that when step (4) is eluted with methanol-water eluent, the mass concentration of methanol used is 2%-6% (preferably 4%). The eluent flow rate is 2.5-4.5 mL/min (preferably 3.5 mL/min).

前面所述的方法,优选的方案是,步骤(3)洗脱方式为甲醇-水梯度洗脱/2%甲醇-水等度洗脱/100%水等度洗脱/5%甲醇-水等度洗脱,优选的是,洗脱液流速为2.5-4.5 mL/min(优选3.5 mL/min)。 The method described above, the preferred solution is that the elution method of step (3) is methanol-water gradient elution/2% methanol-water isocratic elution/100% water isocratic elution/5% methanol-water, etc. Speed elution, preferably, the eluent flow rate is 2.5-4.5 mL/min (preferably 3.5 mL/min).

前面所述的方法,优选的方案是,步骤(4)分离纯化时的洗脱方式为6%甲醇-水等度洗脱/4%甲醇-水等度洗脱/2%甲醇-水等度洗脱/甲醇-水梯度洗脱,优选的是,洗脱液流速为2.5-4.5 mL/min(优选3.5 mL/min)。 For the method described above, the preferred scheme is that the elution method during the separation and purification of step (4) is 6% methanol-water isocratic elution/4% methanol-water isocratic elution/2% methanol-water isocratic elution Elution/methanol-water gradient elution, preferably, the eluent flow rate is 2.5-4.5 mL/min (preferably 3.5 mL/min).

本发明涉及从中药瓜蒌皮中分离纯化嘌呤及嘧啶碱基的方法,步骤为:(1)瓜蒌皮粗提物的制备:取粉碎好的瓜蒌皮药材,用水加热回流提取,提取液经减压浓缩至相对密度为1.2左右,向浓缩液中加入95%乙醇至乙醇的浓度为70%左右,静置72 h,过滤,取上层清液,减压浓缩得粗提物。(2)大孔吸附树脂柱粗分离:将瓜蒌皮粗提物溶于水中,上HPD826型大孔吸附树脂柱进行层析,先用水进行洗脱,再用浓度为5%左右的乙醇-水为洗脱液进行洗脱,分别收集水及5%左右的乙醇-水洗脱液,前者减压浓缩,得样品1,后者减压浓缩,得样品2。(3)样品1的进一步分离纯化:将样品1用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱(250 mm×10 mm I. D., 10 μm,大连江申分离科技有限公司),流动相为甲醇-水,检测波长为254 nm。 (4)样品2的进一步分离纯化:将样品2用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱(250 mm×10 mm I. D., 10 μm,大连江申分离科技有限公司),流动相为甲醇-水,检测波长为254 nm。 The invention relates to a method for separating and purifying purine and pyrimidine bases from the traditional Chinese medicine Trichosanthes peel, the steps are as follows: (1) Preparation of the crude extract of Trichosanthes peel: Take the crushed medicinal material of Trichosanthes peel, heat and reflux with water to extract, and extract Concentrate under reduced pressure to a relative density of about 1.2, add 95% ethanol to the concentrated solution until the concentration of ethanol is about 70%, let it stand for 72 hours, filter, take the supernatant, and concentrate under reduced pressure to obtain a crude extract. (2) Coarse separation with macroporous adsorption resin column: Dissolve the crude extract of Trichosanthes piperi in water, apply HPD826 macroporous adsorption resin column for chromatography, first elute with water, and then use ethanol with a concentration of about 5%- Water was used as the eluent for elution, and water and about 5% ethanol-water eluent were collected respectively. The former was concentrated under reduced pressure to obtain sample 1, and the latter was concentrated under reduced pressure to obtain sample 2. (3) Further separation and purification of sample 1: The sample 1 was separated and purified by semi-preparative high performance liquid chromatography, and the chromatographic column was a YMC ODS-AQ column (250 mm×10 mm I. D., 10 μm, Dalian Jiangshen Separation Technology Co., Ltd.), the mobile phase was methanol-water, and the detection wavelength was 254 nm. (4) Further separation and purification of sample 2: The sample 2 was separated and purified by semi-preparative high-performance liquid chromatography, and the chromatographic column was YMC ODS-AQ column (250 mm×10 mm I. D., 10 μm, Dalian Jiangshen Separation Technology Co., Ltd.), the mobile phase was methanol-water, and the detection wavelength was 254 nm.

本工艺过程绿色环保,对环境无严重危害,综合成本低。 The technological process is green and environmentally friendly, has no serious harm to the environment, and has low overall cost.

本发明从中药瓜蒌皮中分离纯化5种嘌呤及嘧啶碱基的方法,首先采用大孔吸附树脂柱粗分离,再用半制备型高效液相色谱法进行分离纯化,所得目标化合物纯度高,杂质含量极低,这一点可从图5-图9中看出。除此之外,还具有如下优势: The method of the present invention for separating and purifying five kinds of purine and pyrimidine bases from the rind of the traditional Chinese medicine Trichosanthes quinquefolium, first adopts a macroporous adsorption resin column for rough separation, and then uses semi-preparative high-performance liquid chromatography for separation and purification, and the obtained target compound has high purity, The impurity content is extremely low, which can be seen from Figures 5-9. In addition, it also has the following advantages:

(1)提取物经过大孔吸附树脂柱粗分离后可以除去大部分的杂质,使混合物的组成得到简化,可以为后续的分离工作降低难度,并且可以保护半制备型高效液相色谱柱不被污染,有效地延长了色谱柱的使用寿命。 (1) After the extract is roughly separated by a macroporous adsorption resin column, most of the impurities can be removed, the composition of the mixture is simplified, the difficulty of subsequent separation can be reduced, and the semi-preparative high-performance liquid chromatography column can be protected from being Contamination effectively prolongs the service life of the chromatographic column.

(2)使用半制备型高效液相色谱法两次分离纯化就可以同时得到胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤及黄嘌呤5种高纯度单体化合物,方法操作简单,效率高,工艺周期短,节省试剂,降低了生产成本。 (2) Five high-purity monomeric compounds of cytosine, uracil, hypoxanthine, guanine and xanthine can be obtained at the same time by using semi-preparative high-performance liquid chromatography for two separations and purifications. The method is simple to operate and high in efficiency. The process cycle is short, reagents are saved, and production costs are reduced.

(3)纯化过程中不使用对环境和人体危害大的氯仿等有机溶剂,大孔吸附树脂经再生后可以重复使用多次,绿色环保。 (3) Organic solvents such as chloroform, which are harmful to the environment and human body, are not used in the purification process. The macroporous adsorption resin can be reused many times after regeneration, which is green and environmentally friendly.

(4)优化了层析方法的条件(洗脱液的组成和流速),使化合物的纯度和效率都大为提高。 (4) The conditions of the chromatographic method (composition and flow rate of the eluent) were optimized, so that the purity and efficiency of the compound were greatly improved.

附图说明 Description of drawings

图1是样品1的高效液相色谱图。 Figure 1 is a high performance liquid chromatogram of sample 1.

图2是样品2的高效液相色谱图。 Figure 2 is a high performance liquid chromatogram of sample 2.

图3是样品1的半制备型高效液相色谱图。 Figure 3 is a semi-preparative high performance liquid chromatogram of sample 1.

图4是样品2的半制备型高效液相色谱图。 Figure 4 is a semi-preparative high performance liquid chromatogram of sample 2.

图5是胞嘧啶的高效液相色谱图及紫外光谱图。 Fig. 5 is the high performance liquid chromatogram and the ultraviolet spectrogram of cytosine.

图6是尿嘧啶的高效液相色谱图及紫外光谱图。 Fig. 6 is the high-performance liquid chromatogram and the ultraviolet spectrogram of uracil.

图7是次黄嘌呤的高效液相色谱图及紫外光谱图。 Figure 7 is a high performance liquid chromatogram and an ultraviolet spectrogram of hypoxanthine.

图8是鸟嘌呤的高效液相色谱图及紫外光谱图。 Figure 8 is a high performance liquid chromatogram and an ultraviolet spectrogram of guanine.

图9是黄嘌呤的高效液相色谱图及紫外光谱图。 Fig. 9 is a high-performance liquid chromatogram and an ultraviolet spectrogram of xanthine.

具体实施方式 Detailed ways

下面结合实施例和附图详细说明本发明的技术方案,但保护范围不被此限制。实施例中所用设备或原料皆可从市场获得。所用试剂均购自济南试剂总厂,所用水为去离子水。 The technical solutions of the present invention will be described in detail below in conjunction with the embodiments and drawings, but the scope of protection is not limited thereto. The equipment or raw materials used in the examples are all available from the market. All reagents used were purchased from Jinan General Reagent Factory, and the water used was deionized water.

实施例:从中药瓜蒌皮中分离纯化嘌呤及嘧啶碱基的方法,其步骤为: Embodiment: the method for separating and purifying purine and pyrimidine bases from the peel of the traditional Chinese medicine Trichosanthes quince, the steps are:

(1)瓜蒌皮粗提物的制备:瓜蒌皮药材经粉碎后,以水为溶剂加热回流提取4次,合并提取液,减压浓缩至相对密度为1.2左右,向浓缩液中加入95%乙醇至乙醇的浓度为70%左右,静置72 h,过滤,取上层清液,减压浓缩得粗提物。 (1) Preparation of the crude extract of Trichosanthes rind: after crushing the medicinal material of Trichosanthes trichosanthes, heat and reflux extraction with water for 4 times, combine the extracts, concentrate under reduced pressure to a relative density of about 1.2, and add 95 % ethanol until the concentration of ethanol is about 70%, let it stand for 72 h, filter, take the supernatant, and concentrate under reduced pressure to obtain the crude extract.

(2)大孔吸附树脂柱粗分离:将瓜蒌皮粗提物溶于水中,上HPD826型大孔吸附树脂柱进行层析,先用水进行洗脱,再用浓度为5%左右的乙醇-水溶液进行洗脱,分别收集水及5%左右的乙醇-水洗脱液,前者减压浓缩,得样品1,后者减压浓缩,得样品2。 (2) Coarse separation with macroporous adsorption resin column: Dissolve the crude extract of Trichosanthes piperi in water, apply HPD826 macroporous adsorption resin column for chromatography, first elute with water, and then use ethanol with a concentration of about 5%- The aqueous solution was eluted, and water and about 5% ethanol-water eluate were collected respectively. The former was concentrated under reduced pressure to obtain sample 1, and the latter was concentrated under reduced pressure to obtain sample 2.

(3)样品1的进一步分离纯化:将样品1用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱(250 mm×10 mm I. D., 10 μm,大连江申分离科技有限公司),流动相为甲醇-水,检测波长为254 nm。  (3) Further separation and purification of sample 1: The sample 1 was separated and purified by semi-preparative high performance liquid chromatography, and the chromatographic column was a YMC ODS-AQ column (250 mm×10 mm I. D., 10 μm, Dalian Jiangshen Separation Technology Co., Ltd.), the mobile phase was methanol-water, and the detection wavelength was 254 nm. the

(4)样品2的进一步分离纯化:将样品2用半制备型高效液相色谱进行分离纯化,色谱柱为YMC ODS-AQ柱(250 mm×10 mm I. D., 10 μm,大连江申分离科技有限公司),流动相为甲醇-水,检测波长为254 nm。  (4) Further separation and purification of sample 2: The sample 2 was separated and purified by semi-preparative high-performance liquid chromatography, and the chromatographic column was YMC ODS-AQ column (250 mm×10 mm I. D., 10 μm, Dalian Jiangshen Separation Technology Co., Ltd.), the mobile phase was methanol-water, and the detection wavelength was 254 nm. the

收集目标组分馏分,将得到的馏分减压浓缩,即得到所要分离的单体化合物。 The fractions of the target components are collected, and the obtained fractions are concentrated under reduced pressure to obtain the monomer compound to be separated.

发明人通过使用不同浓度的甲醇作流动相,采用不同的洗脱方式,控制洗脱液的流速为2.5-4.5 mL/min(优选3.5 mL/min),优选出了实现本发明目的的纯化条件,有关实验结果如下: The inventor used different concentrations of methanol as the mobile phase, adopted different elution methods, and controlled the flow rate of the eluent to be 2.5-4.5 mL/min (preferably 3.5 mL/min), and optimized the purification conditions to achieve the purpose of the present invention , the relevant experimental results are as follows:

表一 样品1的半制备型高效液相色谱分离条件 Table 1 Semi-preparative HPLC separation conditions of sample 1

 the 洗脱液条件eluent condition 实施例1Example 1 5%甲醇-水等度洗脱5% methanol-water isocratic elution 实施例2Example 2 2%甲醇-水等度洗脱2% methanol-water isocratic elution 实施例3Example 3 100%水等度洗脱100% water isocratic elution 实施例4Example 4 甲醇-水梯度洗脱Methanol-water gradient elution

在实施例1中,采用5%甲醇-水为洗脱液等度洗脱,各成分洗脱时间较短,但相互之间分离效果不够理想,所得成分纯度较低。实施例2中采用2%甲醇-水为洗脱液等度洗脱,各成分之间分离良好,分离时间也较为适宜。实施例3中采用100%水为洗脱液等度洗脱,各成分分离良好,但分离时间太长。实施例4采用甲醇-水梯度洗脱,各成分分离良好,分离时间也可以,但洗脱液由于浓度变化导致回收再利用存在较大困难。 In Example 1, 5% methanol-water was used as the eluent for isocratic elution, and the elution time of each component was shorter, but the separation effect between them was not ideal, and the purity of the obtained components was low. In Example 2, 2% methanol-water was used as the eluent for isocratic elution, and the components were separated well, and the separation time was also relatively appropriate. In Example 3, 100% water was used as the eluent for isocratic elution, and the components were separated well, but the separation time was too long. Example 4 adopts methanol-water gradient elution, the components are separated well, and the separation time is also acceptable, but the recovery and reuse of the eluate is difficult due to concentration changes.

图3是当选用实施例2体系时的色谱图,由图3可见,各成分分离良好,分离时间也较为适宜。根据色谱图收集各峰组分,回收溶剂后,即可得到相应高纯度化合物。经高效液相色谱面积归一化法分析测试,实施例2所得到的各个组分的纯度很高,均在98%以上,这一点可从图5-图6中看出。 Fig. 3 is the chromatogram when the system of Example 2 is selected for use, as can be seen from Fig. 3, each component is well separated, and the separation time is also comparatively suitable. The peak components are collected according to the chromatogram, and the corresponding high-purity compound can be obtained after recovering the solvent. After analysis and testing by the high performance liquid chromatography area normalization method, the purity of each component obtained in Example 2 is very high, all above 98%, which can be seen from Figures 5-6.

表二 样品2的半制备型高效液相色谱分离条件 Table 2 The semi-preparative high performance liquid chromatography separation conditions of sample 2

 the 洗脱液条件eluent condition 实施例5Example 5 6%甲醇-水等度洗脱6% methanol-water isocratic elution 实施例6Example 6 4%甲醇-水等度洗脱4% methanol-water isocratic elution 实施例7Example 7 2%甲醇-水等度洗脱2% methanol-water isocratic elution 实施例8Example 8 甲醇-水梯度洗脱Methanol-water gradient elution

 在实施例5中,采用6%甲醇-水为洗脱液等度洗脱,各成分洗脱时间较短,但相互之间分离效果不够理想,所得成分纯度较低。实施例6中采用4%甲醇-水为洗脱液等度洗脱,各成分之间分离良好,分离时间也较为适宜。实施例7中采用2%甲醇-水为洗脱液等度洗脱,各成分分离良好,但分离时间太长。实施例8采用甲醇-水梯度洗脱,各成分分离良好,分离时间也可以,但洗脱液由于浓度变化导致回收再利用存在较大困难。 In Example 5, 6% methanol-water was used as the eluent for isocratic elution, and the elution time of each component was shorter, but the separation effect between them was not ideal, and the purity of the obtained components was low. In Example 6, 4% methanol-water was used as the eluent for isocratic elution, and the components were separated well, and the separation time was also relatively appropriate. In Example 7, 2% methanol-water was used as the eluent for isocratic elution, and the components were separated well, but the separation time was too long. Example 8 adopts methanol-water gradient elution, the components are separated well, and the separation time is also acceptable, but the recovery and reuse of the eluate is difficult due to concentration changes.

图4是当选用实施例6体系时的色谱图,由图4可见,各成分分离良好,分离时间也较为适宜。根据色谱图收集各峰组分,回收溶剂后,即可得到相应高纯度化合物。经高效液相色谱面积归一化法分析测试,实施例6所得到的各个组分的纯度很高,均在98%以上,这一点可从图7-图9中看出。 Fig. 4 is the chromatogram when selecting embodiment 6 system for use, as can be seen from Fig. 4, each component is separated well, and separation time is also comparatively suitable. The peak components are collected according to the chromatogram, and the corresponding high-purity compound can be obtained after recovering the solvent. After analysis and testing by the high performance liquid chromatography area normalization method, the purity of each component obtained in Example 6 is very high, all above 98%, which can be seen from Figures 7-9.

根据核磁共振氢谱和碳谱的测试,对所得峰组分进行鉴定,得到了胞嘧啶、尿嘧啶、次黄嘌呤、鸟嘌呤及黄嘌呤。经现代波谱数据证实所提取纯化得到的5个化合物的结构式如下: According to the test of H NMR spectrum and C NMR spectrum, the obtained peak components were identified, and cytosine, uracil, hypoxanthine, guanine and xanthine were obtained. The structural formulas of the extracted and purified five compounds confirmed by modern spectral data are as follows:

5种化合物的鉴定结果如下:  The identification results of the five compounds are as follows:

化合物I(胞嘧啶):1H-NMR(400 MHz,DMSO-d6δ ppm:10.47(1H,br s,1-H),7.32(1H,d,J=6.8 Hz,6-H),7.04(2H,br s,4-NH2),5.57(1H,d,J=6.8 Hz,5-H)。13C-NMR(100 MHz,DMSO-d6δ ppm:166.6(C-4),156.8(C-2),142.5(C-6),92.4(C-5)。 Compound I (cytosine): 1 H-NMR (400 MHz, DMSO-d 6 ) δ ppm: 10.47 (1H, br s, 1-H), 7.32 (1H, d, J = 6.8 Hz, 6-H) , 7.04 (2H, br s, 4-NH 2 ), 5.57 (1H, d, J =6.8 Hz, 5-H). 13 C-NMR (100 MHz, DMSO-d 6 ) δ ppm: 166.6 (C-4), 156.8 (C-2), 142.5 (C-6), 92.4 (C-5).

化合物II(尿嘧啶):1H-NMR(400 MHz,DMSO-d6δ ppm:10.48(2H,br s,1-H,3-H),7.39(1H,d,J=7.6 Hz,H-6),5.44(1H,d,J=7.6 Hz,H-5)。13C-NMR(100 MHz,DMSO-d6δ ppm:164.1(C-4),151.4(C-2),142.1(C-6),100.0(C-5)。 Compound II (uracil): 1 H-NMR (400 MHz, DMSO-d 6 ) δ ppm: 10.48 (2H, br s, 1-H, 3-H), 7.39 (1H, d, J = 7.6 Hz, H-6), 5.44 (1H,d, J =7.6 Hz, H-5). 13 C-NMR (100 MHz, DMSO-d 6 ) δ ppm: 164.1 (C-4), 151.4 (C-2), 142.1 (C-6), 100.0 (C-5).

化合物III(次黄嘌呤):1H-NMR(400 MHz,DMSO-d6δ ppm:13.20(1H,br s,9-H),12.29(1H,br s,1-H),8.18(1H,s,2-H),8.11(1H,s,H-8)。13C-NMR(100 MHz,DMSO-d6δ ppm:155.6(C-6),153.7(C-4),152.7(C-8),144.1(C-2),119.5(C-5)。 Compound III (hypoxanthine): 1 H-NMR (400 MHz, DMSO-d 6 ) δ ppm: 13.20 (1H, br s, 9-H), 12.29 (1H, br s, 1-H), 8.18 ( 1H, s, 2-H), 8.11 (1H, s, H-8). 13 C-NMR (100 MHz, DMSO-d 6 ) δ ppm: 155.6 (C-6), 153.7 (C-4), 152.7 (C-8), 144.1 (C-2), 119.5 (C-5) .

化合物IV(鸟嘌呤):1H-NMR(400 MHz,D2O)δ ppm:7.34(1H,s,8-H)。13C-NMR(100 MHz,D2O)δ ppm:155.8(C-6),149.1(C-4),147.2(C-2),136.7 (C-8),106.5(C-5)。 Compound IV (guanine): 1 H-NMR (400 MHz, D 2 O) δ ppm: 7.34 (1H, s, 8-H). 13 C-NMR (100 MHz, D 2 O) δ ppm: 155.8 (C-6), 149.1 (C-4), 147.2 (C-2), 136.7 (C-8), 106.5 (C-5).

化合物V(黄嘌呤):1H-NMR(400 MHz,D2O)δ ppm:7.35(1H,s,8-H)。 13C-NMR(100 MHz,D2O)δ ppm:155.4(C-6),152.2(C-2),150.4(C-4),141.6(C-8),106.9(C-5)。 Compound V (xanthine): 1 H-NMR (400 MHz, D 2 O) δ ppm: 7.35 (1H, s, 8-H). 13 C-NMR (100 MHz, D 2 O) δ ppm: 155.4 (C-6), 152.2 (C-2), 150.4 (C-4), 141.6 (C-8), 106.9 (C-5).

应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例。还可以有很多变形。本领域的普通技术人员,从此文件中所公开提到或是联想到的,均应认为是本专利所要保护的范围。 It should be noted that the specific embodiments are only representative examples of the present invention, and obviously the technical solution of the present invention is not limited to the above-mentioned embodiments. Many variants are also possible. Those of ordinary skill in the art should consider the disclosure, mention or association of this document as the scope of protection of this patent.

Claims (13)

1. the method for separation and purification purine and pyrimidine bases from Chinese medicine Snakegourd Peel, it is characterized in that, step is:
(1) preparation of Snakegourd Peel crude extract: get the Snakegourd Peel medicinal material crushed, use water heating and refluxing extraction, extracting solution is 1.2 through being evaporated to relative density, in concentrated solution, add 95% ethanol to the concentration of ethanol is 70%, leave standstill 72h, filter, get supernatant liquid, concentrating under reduced pressure obtains crude extract;
(2) macroporous adsorptive resins roughing out: by soluble in water for Snakegourd Peel crude extract, upper HPD826 type macroporous adsorptive resins carries out chromatography, first carry out wash-out with water, wash-out is carried out again with the ethanol-water solution that concentration is 5%, collect the alcohol-water elutriant of water and 5% respectively, the former concentrating under reduced pressure, obtains sample 1, the latter's concentrating under reduced pressure, obtains sample 2;
(3) the further separation and purification of sample 1: sample 1 Semipreparative chromatography is carried out separation and purification, chromatographic column is YMC ODS-AQ post, and moving phase is methanol-water, and determined wavelength is 254nm;
(4) the further separation and purification of sample 2: sample 2 Semipreparative chromatography is carried out separation and purification, chromatographic column is YMC ODS-AQ post, and moving phase is methanol-water, and determined wavelength is 254nm;
Collect target components cut, by the cut concentrating under reduced pressure obtained, namely obtain cytosine(Cyt), uridylic, xanthoglobulin, guanine and xanthine monomeric compound.
2. method according to claim 1, is characterized in that, during step (1) reflux, extraction time is 1-3 hour.
3. method according to claim 2, is characterized in that, step (1) extraction time is 1.5-2.5 hour.
4. method according to claim 3, is characterized in that, step (1) extraction time is 2 hours.
5. method according to claim 1, is characterized in that, step (1) extraction time is 2-6 time.
6. method according to claim 1, is characterized in that, step (1) extraction time is 3-5 time.
7. method according to claim 1, is characterized in that, step (1) extraction time is 4 times.
8. method according to claim 1, is characterized in that, step (3) type of elution is methanol-water gradient elution/2% methanol-water isocratic elution/100% water isocratic elution/5% methanol-water isocratic elution.
9. method according to claim 8, is characterized in that, eluent flow rate is 2.5-4.5mL/min.
10. method according to claim 8, is characterized in that, eluent flow rate is 3.5mL/min.
11. methods according to claim 1, is characterized in that, type of elution during step (4) separation and purification is 6% methanol-water isocratic elution/4% methanol-water isocratic elution/2% methanol-water isocratic elution/methanol-water gradient elution.
12. methods according to claim 11, is characterized in that, eluent flow rate is 2.5-4.5mL/min.
13. methods according to claim 12, is characterized in that, eluent flow rate is for selecting 3.5mL/min.
CN201310240459.4A 2013-06-18 2013-06-18 Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark Active CN103304490B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310240459.4A CN103304490B (en) 2013-06-18 2013-06-18 Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310240459.4A CN103304490B (en) 2013-06-18 2013-06-18 Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark

Publications (2)

Publication Number Publication Date
CN103304490A CN103304490A (en) 2013-09-18
CN103304490B true CN103304490B (en) 2015-02-18

Family

ID=49130250

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310240459.4A Active CN103304490B (en) 2013-06-18 2013-06-18 Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark

Country Status (1)

Country Link
CN (1) CN103304490B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105541944B (en) * 2016-03-02 2017-12-26 上海上药第一生化药业有限公司 The preparation method and its usage of chemical composition in Pericarpium Trichosanthis injection
CN105646628B (en) * 2016-03-02 2018-01-23 上海上药第一生化药业有限公司 The preparation method and its usage of chemical composition in Pericarpium Trichosanthis injection
CN105669806B (en) * 2016-03-02 2018-01-23 上海上药第一生化药业有限公司 The preparation method and its usage of chemical composition in Pericarpium Trichosanthis injection
CN110330541B (en) * 2019-05-22 2023-03-21 南阳师范学院 Method for separating 5 '-guanine nucleotide and 5' -cytosine nucleotide
CN111603499A (en) * 2020-05-22 2020-09-01 甘肃岷海医药科技有限公司 Traditional Chinese medicine for preventing and treating cancer and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62108813A (en) * 1985-11-06 1987-05-20 Tsumura Juntendo Inc Inhibitor of blood platelet aggregation
US7618657B2 (en) * 2003-02-21 2009-11-17 Ultra Biotech Limited Active ingredients preparation and single compound purification from traditional Chinese herbal medicine Fructus Trichosanthis and uses thereof
CN100408999C (en) * 2005-07-12 2008-08-06 天津农学院 Determination method of balsum pear saponin
CN101152233B (en) * 2006-09-25 2010-10-13 山东轩竹医药科技有限公司 Pharmaceutical composition of snakegourd fruit and folium ginkgo

Also Published As

Publication number Publication date
CN103304490A (en) 2013-09-18

Similar Documents

Publication Publication Date Title
CN103304613B (en) A kind of method of separation and purification 4 kinds of ucleosides chemical compositions from Snakegourd Peel
CN101735231B (en) Method for extracting purified dendrobine from dendrobium stem
CN103304490B (en) Method for separating and purifying five purine and pyrimidine bases from trichosanthes bark
CN102875562B (en) Method for preparing psoralen and isopsoralen or extract containing psoralen and isopsoralen
CN102846784B (en) Aquatic extract of vine vine, its preparation method and use
CN103641718B (en) Method for separating and purifying chlorogenic acid and 3,5-dicaffeoylquinic acid from honeysuckle flower
CN102285994B (en) Method for separating and purifying fangchinoline and tetrandrine from stephania tetrandra
CN102228515B (en) Separation and enrichment method of total flavones and total alkaloids of Lotus Plumule
CN102070485B (en) Method for Separating and Purifying Active Ingredient Golden Amino Alcohol Ester from Clematis paniculata, a Chinese Medicinal Material
CN108218948B (en) Preparation method of sodium aescinate
CN104557834B (en) A kind of isolated and purified pinocembrin, Chrysin and method of Galangin from China's Water extracts of propolis
WO2012061984A1 (en) Method for preparing albiflorin and paeoniflorin
CN103304611B (en) A kind of method of separation and purification 3 kinds of flavonoid glycosides from Snakegourd Peel
CN103342689B (en) Method for separation and purification of luteolin, apigenin and diosmetin in trichosanthes peel
CN102526127A (en) Flash type extraction method for active constituents in cordyceps militaris
CN109879919B (en) A kind of method for separating and preparing three kinds of flavonoid glycosides from jujube seed
CN104327066B (en) Method for rapidly and efficiently extracting carboline alkaloids
CN105017273A (en) Method for extracting, separating and purifying psoralen and isopsoralen from fructus psoraleae
CN106188198B (en) A kind of method of cAMP in high efficiency extraction jujube
CN107417692A (en) A kind of method of purification of chlorinated nitidine
CN105294789B (en) A kind of preparation method of high-purity salidroside
CN105016982B (en) A method for extracting, separating and purifying honokiol and magnolol from magnolia bark
CN117815351A (en) Preparation method of lung-heat clearing and toxin expelling granule
CN103965276B (en) The method of fast separating and purifying monomeric compound from Lindley Eupatorium Herb
CN104557520B (en) A method for separating and purifying caffeic acid, ferulic acid and isoferulic acid from Chinese propolis water extract

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICIN

Free format text: FORMER OWNER: LIAOCHENG UNIVERSITY

Effective date: 20150106

Owner name: SHANGHAI NO.1 BIO-CHEMICAL PHARMACETICAL INDUSTRY

Effective date: 20150106

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Li Aifeng

Inventor after: Sun Ailing

Inventor after: Liu Renmin

Inventor after: Zhang Yongqing

Inventor after: Huang Zhenhui

Inventor before: Li Aifeng

Inventor before: Zhang Yongqing

Inventor before: Liu Renmin

Inventor before: Sun Ailing

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: LI AIFENG ZHANG YONGQING LIU RENMIN SUN AILING TO: LI AIFENG SUN AILING LIU RENMIN ZHANG YONGQING HUANG ZHENHUI

Free format text: CORRECT: ADDRESS; FROM: 252059 LIAOCHENG, SHANDONG PROVINCE TO: 250300 JINAN, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20150106

Address after: 250300, 4655, University Road, Changqing District, Shandong, Ji'nan

Applicant after: Shandong University of Traditional Chinese Medicine

Applicant after: Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd.

Applicant after: Liaocheng University

Address before: 252059 Hunan Road, Dongchangfu, Shandong, No. 1,

Applicant before: Liaocheng University

C14 Grant of patent or utility model
GR01 Patent grant